Ibis Reproductive Health

Ibis Reproductive Health is a global non-profit research organization dedicated to improving sexual and reproductive health through clinical and social science research. The organization focuses on three primary areas: increasing access to safe abortion care, expanding contraceptive options, and integrating HIV and reproductive health services. Ibis is notably recognized for leading the "Free the Pill" campaign, which played a pivotal role in the FDA approval of the first over-the-counter daily oral contraceptive in the United States. By conducting rigorous research and partnering with advocates, the organization aims to influence policy and clinical practice to ensure high-quality reproductive healthcare is accessible to all. Their work spans across the United States, Sub-Saharan Africa, and other global regions.